Jennifer A Ligibel

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. doi request reprint Lifestyle factors in cancer survivorship
    Jennifer Ligibel
    Dana Farber Cancer Institute, Boston, MA 02215, USA
    J Clin Oncol 30:3697-704. 2012
  2. pmc Patterns of bone density evaluation in a community population treated with aromatase inhibitors
    Jennifer A Ligibel
    Dana Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA
    Breast Cancer Res Treat 134:1305-13. 2012
  3. pmc Impact of a telephone-based physical activity intervention upon exercise behaviors and fitness in cancer survivors enrolled in a cooperative group setting
    Jennifer A Ligibel
    Dana Farber Cancer Institute, 450 Brookline Ave Boston, Boston, MA 02215, USA
    Breast Cancer Res Treat 132:205-13. 2012
  4. ncbi request reprint Obesity and breast cancer
    Jennifer Ligibel
    Department of Adult Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02215, USA
    Oncology (Williston Park) 25:994-1000. 2011
  5. doi request reprint Physical and psychological outcomes among women in a telephone-based exercise intervention during adjuvant therapy for early stage breast cancer
    Jennifer A Ligibel
    Dana Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA
    J Womens Health (Larchmt) 19:1553-9. 2010
  6. doi request reprint Impact of a mixed strength and endurance exercise intervention on levels of adiponectin, high molecular weight adiponectin and leptin in breast cancer survivors
    Jennifer A Ligibel
    Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Boston, MA 02115, USA
    Cancer Causes Control 20:1523-8. 2009
  7. doi request reprint Physical activity behaviors in women with newly diagnosed ductal carcinoma-in-situ
    Jennifer A Ligibel
    Dana Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA
    Ann Surg Oncol 16:106-12. 2009
  8. doi request reprint Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors
    Jennifer A Ligibel
    Dana Farber Cancer Institute, Brigham and Women s Hospital, Harvard Medical School, Channing Laboratory, Boston, MA, USA
    J Clin Oncol 26:907-12. 2008
  9. pmc Aromatase inhibitors as adjuvant therapy for postmenopausal women: a therapeutic advance but many unresolved questions
    Jennifer A Ligibel
    Harvard Medical School, Dana Farber Cancer Institute and Brigham and Women s Hospital, Boston, Massachusetts, USA
    Breast Cancer Res 7:255-7. 2005
  10. ncbi request reprint Role of adjuvant and posttreatment exercise programs in breast health
    Jennifer A Ligibel
    Dana Farber Cancer Institute and Harvard Medical School, Boston, MA 02115, USA
    J Natl Compr Canc Netw 9:251-6. 2011

Detail Information

Publications17

  1. doi request reprint Lifestyle factors in cancer survivorship
    Jennifer Ligibel
    Dana Farber Cancer Institute, Boston, MA 02215, USA
    J Clin Oncol 30:3697-704. 2012
    ..This article reviews the evidence that links lifestyle factors to cancer outcomes, provides clinical recommendations for cancer survivors, and describes future directions for lifestyle research in cancer survivors...
  2. pmc Patterns of bone density evaluation in a community population treated with aromatase inhibitors
    Jennifer A Ligibel
    Dana Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA
    Breast Cancer Res Treat 134:1305-13. 2012
    ..Attention is needed to insure that unnecessary fractures are avoided in breast cancer patients taking AIs...
  3. pmc Impact of a telephone-based physical activity intervention upon exercise behaviors and fitness in cancer survivors enrolled in a cooperative group setting
    Jennifer A Ligibel
    Dana Farber Cancer Institute, 450 Brookline Ave Boston, Boston, MA 02215, USA
    Breast Cancer Res Treat 132:205-13. 2012
    ..Lifestyle intervention research is feasible in a cooperative group setting...
  4. ncbi request reprint Obesity and breast cancer
    Jennifer Ligibel
    Department of Adult Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02215, USA
    Oncology (Williston Park) 25:994-1000. 2011
    ....
  5. doi request reprint Physical and psychological outcomes among women in a telephone-based exercise intervention during adjuvant therapy for early stage breast cancer
    Jennifer A Ligibel
    Dana Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA
    J Womens Health (Larchmt) 19:1553-9. 2010
    ..Studies have suggested that decreases in physical activity during treatment may contribute to weight gain in breast cancer patients...
  6. doi request reprint Impact of a mixed strength and endurance exercise intervention on levels of adiponectin, high molecular weight adiponectin and leptin in breast cancer survivors
    Jennifer A Ligibel
    Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Boston, MA 02115, USA
    Cancer Causes Control 20:1523-8. 2009
    ..This study examines the impact of exercise upon levels of adiponectin, high molecular weight adiponectin (HMWA), and leptin in breast cancer survivors...
  7. doi request reprint Physical activity behaviors in women with newly diagnosed ductal carcinoma-in-situ
    Jennifer A Ligibel
    Dana Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA
    Ann Surg Oncol 16:106-12. 2009
    ..Women who underwent mastectomy, as well as women who were more anxious, were more likely to decrease their level of physical activity. Women with DCIS might benefit from targeted interventions to increase physical activity...
  8. doi request reprint Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors
    Jennifer A Ligibel
    Dana Farber Cancer Institute, Brigham and Women s Hospital, Harvard Medical School, Channing Laboratory, Boston, MA, USA
    J Clin Oncol 26:907-12. 2008
    ..We sought to analyze whether exercise lowered insulin concentrations in breast cancer survivors...
  9. pmc Aromatase inhibitors as adjuvant therapy for postmenopausal women: a therapeutic advance but many unresolved questions
    Jennifer A Ligibel
    Harvard Medical School, Dana Farber Cancer Institute and Brigham and Women s Hospital, Boston, Massachusetts, USA
    Breast Cancer Res 7:255-7. 2005
    ..Ongoing trials will compare these approaches and guide the use of these agents in the years to come...
  10. ncbi request reprint Role of adjuvant and posttreatment exercise programs in breast health
    Jennifer A Ligibel
    Dana Farber Cancer Institute and Harvard Medical School, Boston, MA 02115, USA
    J Natl Compr Canc Netw 9:251-6. 2011
    ..This article reviews the growing evidence that exercise could be an important part of breast cancer survivorship, and describes current exercise guidelines for breast cancer survivors...
  11. doi request reprint Risk of myocardial infarction, stroke, and fracture in a cohort of community-based breast cancer patients
    Jennifer A Ligibel
    Department of Adult Oncology, Dana Farber Cancer Institute, Boston, MA, USA
    Breast Cancer Res Treat 131:589-97. 2012
    ..The side effect profile of AIs in this community-based population was similar to that seen in clinical trials. These findings provide reassurance that AIs appear to be associated with few serious side effects...
  12. pmc A phase II study of sagopilone (ZK 219477; ZK-EPO) in patients with breast cancer and brain metastases
    Rachel A Freedman
    Department of Medical Oncology, Dana Farber Cancer Institute, 44 Binney Street, Harvard Medical School, Boston, MA 02115, USA
    Clin Breast Cancer 11:376-83. 2011
    ..We observed modest activity with a central nervous system objective response rate of 13.3%; however, median PFS was disappointing. Further studies should focus on other agents to treat this challenging clinical problem...
  13. ncbi request reprint Clinical differences among the aromatase inhibitors
    Jennifer A Ligibel
    Harvard Medical School, Women s Hospital, Boston, Massachusetts 02115, USA
    Clin Cancer Res 9:473S-9S. 2003
    ..This article explores the efficacy and tolerability of the aromatase inhibitors in both the metastatic and the adjuvant settings...
  14. ncbi request reprint New NCCN guidelines for survivorship care
    Jennifer A Ligibel
    Department of Medicine, Harvard Medical School, and Adult Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA jligibel partners org
    J Natl Compr Canc Netw 11:640-4. 2013
    ..They also discuss implementing new recommendations on survivorship assessment in the clinic...
  15. pmc Impact of diabetes on oncologic outcome of colorectal cancer patients: colon vs. rectal cancer
    Justin Y Jeon
    Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
    PLoS ONE 8:e55196. 2013
    ..To evaluate the impact of diabetes on outcomes in colorectal cancer patients and to examine whether this association varies by the location of tumor (colon vs. rectum)...
  16. doi request reprint Mucinous breast carcinoma: a large contemporary series
    Christina R Barkley
    Department of Surgery, Brigham and Women s Hospital, Boston, MA, USA
    Am J Surg 196:549-51. 2008
    ..Mucinous breast cancer is typically associated with a favorable prognosis. This study aimed to assess recent trends and prognostic features in the treatment of mucinous breast carcinoma...
  17. ncbi request reprint Trastuzumab/chemotherapy combinations in metastatic breast cancer
    Jennifer A Ligibel
    Harvard Medical School, Boston, MA 02115, USA
    Semin Oncol 29:38-43. 2002
    ....